Foresight Diagnostics: Sandra Horning
Jan 19, 2022
Liquid biopsy-based cancer diagnostics firm Foresight Diagnostics has appointed Sandra Horning to its new scientific advisory board. She is a professor emerita at Stanford University and is a cofounder and board member of EQRx. She also serves on the boards of Gilead Sciences, Moderna, and Olema Oncology. Previously, Horning was CMO and head of global product development at Genentech/Roche.